©2024 Stanford Medicine
T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus
Not Recruiting
Trial ID: NCT00212329
Purpose
Type 1 diabetes is a condition that is caused in part by an abnormality of the immune system which occurs when T cells, which are part of the immune system, damage the insulin secreting cells (islet cells) in the pancreas. Although it is known that T cells are important mediators of the disease, progress in the development of reliable T cell assays has been modest. The purpose of this study is to learn which T cell assays are most reliable and reproducible so that the investigators can improve their understanding about how type 1 diabetes occurs.
Official Title
A Comparative Study Between the Cytokine Elispot, Tetramer, Immunoblot, and T Cell Proliferation Assays Using Fresh Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
To be eligible, individuals with type 1 diabetes must be:
* Diagnosed with type 1 diabetes within one year of first study visit
* 8-35 years of age at time of first visit
* Weigh \> 40 kg (88 lbs) at time of first visit
* Individuals who will serve as control subjects who do not have type 1 diabetes cannot have a first degree or second degree relative with type 1 diabetes.
Exclusion Criteria:
Individuals must not:
* Have any major illness
* Be taking any steroid medications
* If female, should not be pregnant or breastfeeding.
Intervention(s):
procedure: T Cell Proliferation and Autoreactivity Assays
procedure: Cellular Immunoblot Assays
procedure: Tetramer Studies
procedure: Cytokine ELISPOT
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Alison Rigby
8772325182